Doyle James Edward

Average Profitability
138.27%
Insider Buys Quantity
1
Insider Buys Sum
$64,300.00
Insider Sells Quantity
12
Insider Sells Sum
$3M

Insider Activity of Doyle James Edward

According to the SEC Form 4 filings, Doyle James Edward, being in a position of

  1. director at Exact Sciences Corporation,
    оver the last 12 months, has bought 0 shares, and sold 2000 shares for $115,000,
    over all time since 2016-03-08, has bought 10000 shares for $64,300, and sold 35029 shares for $3M.

The largest purchase of all time was on 2016-03-08 and amounted to 10000 shares of Exact Sciences Corporation for $64,300.

The largest sale of all time was on 2019-07-31 and amounted to 5616 shares of Exact Sciences Corporation for $662,295.

Biography of Doyle James Edward

No biography is available at this moment.

2024-03-01SaleExact Sciences Corporation
EXAS
director
2,000
0.0011%
$57.50$115,000+0.85%
2023-07-27SaleExact Sciences Corporation
EXAS
director
2,000
0.0011%
$97.42$194,840-32.42%
2023-06-09SaleExact Sciences Corporation
EXAS
director
1,402
0.0008%
$90.51$126,895-25.24%
2023-05-26SaleExact Sciences Corporation
EXAS
director
2,000
0.0011%
$80.62$161,240-19.4%
2021-07-30SaleExact Sciences Corporation
EXAS
director
2,640
0.0016%
$111.17$293,489-29.5%
2021-02-26SaleExact Sciences Corporation
EXAS
director
2,000
0.0011%
$130.11$260,220-27.1%
2020-07-31SaleExact Sciences Corporation
EXAS
director
2,539
0.0017%
$94.00$238,666+29.2%
2020-02-28SaleExact Sciences Corporation
EXAS
director
2,000
0.0013%
$77.54$155,080+13.75%
2019-07-31SaleExact Sciences Corporation
EXAS
director
5,616
0.0044%
$117.93$662,295-22.53%
2019-02-28SaleExact Sciences Corporation
EXAS
director
4,000
0.0033%
$96.00$384,000+5.02%
2018-07-30SaleExact Sciences Corporation
EXAS
director
2,636
0.0022%
$58.86$155,155+45.7%
2018-04-10SaleExact Sciences Corporation
EXAS
director
6,196
0.005%
$40.97$253,850+66.3%
2016-03-08PurchaseExact Sciences Corporation
EXAS
director
10,000
0.0104%
$6.43$64,300+138.27%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.